Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Pre-participation screening of young competitive athletes for prevention of sudden cardiac death 3. The Job Market for 2008-2009: Compensation 4. Renal Artery Stenosis 5. AHA Guidelines on Cardiac CT for Assessing Coronary Artery Disease
Your Article Summary
See Latest ArticlesBeta-blockers for hypertension: Are they going out of style?
Cleveland Clinic Journal of Medicine, 09/03/09
Che QI et al. – Although beta–blockers lower blood pressure in most patients, the outcomes of clinical hypertension trials of these drugs have been disappointing, and the value of beta–blockers in treating hypertensive patients who do not have compelling indications for them has been questioned. Until these drugs are proved beneficial, they should be used as antihypertensive therapy only in patients with compelling cardiac indications for them or as add–on agents in those with uncontrolled or resistant hypertension.
- No evidence exists that beta–blockers prevent first episodes of cardiovascular events in patients with hypertension, and in some trials, outcomes were worse with beta–blockers than with antihypertensive drugs of other classes.
- Younger hypertensive patients have hemodynamic characteristics that would seem to be amenable to beta–blocker therapy. However, most clinical trials of beta blockers did not stratify patients by age.
- Most trials of the antihypertensive effects of beta–blockers used atenolol (Tenormin), which is not an ideal representative of this class of drugs.
- Newer beta–blockers with vasodilatory properties may overcome the adverse effect of increased peripheral vascular resistance that occurs with older agents such as atenolol.
Related Articles
Preventing Heart Attacks During Surgery: Drugs Not Foolproof
Ivanhoe, 11/06/09
Relevance Score: 85%
Perioperative Use of beta-Blockers in the Elderly Patient
Anesthesiology Clinics, 10/15/09
Relevance Score: 84%
Mucosal (oral and vulval) lichen planus in women: are angiotensin-converting enzyme inhibitors protective, and beta-blockers and non-steroidal anti-inflammatory drugs associated with the condition
Clinical and Experimental Dermatology, 10/30/09
Relevance Score: 80%
Use and cost of branded and generic drugs in patients with coronary heart disease-results from a prospective survey of 1008 patients in two London hospitals
QJM: An International Journal of Medicine, 10/16/09
Relevance Score: 80%
Respiratory Effects of beta-blocker Therapy in Heart Failure
Cardiovascular Drugs and Therapy, 10/06/09
Relevance Score: 80%
Today in Clinical Pharmacology...keeping you current
Receive free subspecialty "5-minute updates" via email
Year Two Assessment of Fenofibric Acid and Moderate-Dose Statin Combination: A Phase 3, Open-Label, Extension Study
Clinical Drug Investigation, 12/11/09
Recent Caffeine Ingestion Reduces Adenosine Efficacy in the Treatment of Paroxysmal Supraventricular Tachycardia
Academic Emergency Medicine, 12/11/09
Perioperative Intravenous Amiodarone Does Not Reduce the Burden of Atrial Fibrillation in Patients Undergoing Cardiac Valvular Surgery
Anesthesiology, 12/10/09
Today in Hypertension...keeping you current
Receive free subspecialty "5-minute updates" via email
Evaluation of prescribing patterns in a German network of CAM physicians for the treatment of patients with hypertension: a prospective observational study
BMC Family Practice, 12/11/09
Predictors of cardiovascular events in patients with hypertension and left ventricular hypertrophy: the Losartan Intervention For Endpoint reduction in hypertension study
Blood Pressure, 12/11/09
Drug treatment of prehypertension: Not now, not ever
Blood Pressure, 12/11/09
Sponsor
Article Search
Sponsor
Sponsor